Akèy › Tit travay › Regulatory Affairs Specialist
Regulatory Affairs Specialist: Salè H-1B
436 aplikasyon kondisyon travay te itilize tit travay Regulatory Affairs Specialist. Salè baz medyàn ofri $78,374; mwatye mitan $69,000–$90,000.
Demann (LCA)436
Salè medyan ofri$78,374
Mwatye salè yo$69,000–$90,000
10yèm–90yèm pousantaj$60,511–$107,340
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| Medtronic, Inc. | 30 | $79,082 |
| Intellectt, Inc. | 13 | $87,360 |
| Freyr,Inc. | 13 | $70,408 |
| Intuitive Surgical Operations, Inc. | 12 | $114,800 |
| The Veritas Healthcare Solutions LLC | 8 | $73,424 |
| Covidien LP | 8 | $68,328 |
| Carnegie Pharmaceuticals LLC | 8 | $64,000 |
| RevereIT LLC | 8 | $86,320 |
| Sure-Fi Inc. | 7 | $62,400 |
| The Fountain Group, LLC | 6 | $89,440 |
| Cronus Pharma LLC | 5 | $73,710 |
| Tata Elxsi Limited | 5 | $78,458 |
| Nutra-Med Packaging LLC | 5 | $77,250 |
| Splint Pharma LLC | 4 | $65,644 |
| Populus Group LLC | 4 | $120,640 |
| Heraeus Medical Components LLC | 4 | $105,302 |
| Abbott Diabetes Care Inc. | 4 | $84,115 |
| Aurora Lumira Consulting LLC | 4 | $90,000 |
| Mizuho Orthopedic Systems, Inc. | 3 | $102,000 |
| Zimmer, Inc. | 3 | $74,464 |
| Penumbra, Inc. | 3 | $104,478 |
| Zoll Medical Corporation | 3 | $83,200 |
| Madagoni LLC | 3 | $70,720 |
| Yosemite Clean Energy, LLC | 3 | $81,308 |
| STAAR Surgical Company | 3 | $100,000 |
| Viant Medical, LLC | 2 | $103,875 |
| Novozen Healthcare LLC. | 2 | $81,359 |
| Hemostasis, LLC | 2 | $97,255 |
| AviaGames, Inc. | 2 | $102,546 |
| Sathram Corporation | 2 | $75,962 |
| Evaric Pharmaceuticals Inc. | 2 | $76,000 |
| Procept BioRobotics Corporation | 2 | $83,767 |
| Sendx Medical, Inc. | 2 | $109,982 |
| Zaidan Staffing LLC | 2 | $78,000 |
| Maven Companies, Inc. | 2 | $62,400 |
| Ascent Pharmaceuticals, Inc. | 2 | $86,000 |
| Specialty PharmaSource LLC | 2 | $61,500 |
| LG H&H USA, Inc. | 2 | $111,634 |
| Bracco AMT, Inc. | 2 | $76,756 |
| Garonit Pharmaceutical Inc. | 2 | $57,970 |
| Coach the Coach Academy, LLC | 2 | $40,000 |
| Aplomb Technologies Inc. | 2 | $80,541 |
| Vision Music Inc | 2 | — |
| Integrated Resources, Inc. | 2 | $111,280 |
| Becton, Dickinson and Company | 2 | $92,000 |
| SogoTrade, Inc. | 2 | $47,450 |
| Celegence LLC | 2 | $106,490 |
| Discovery SCM USA LTD | 2 | — |
| Sunrise Pharmaceutical Inc. | 2 | $76,980 |
| Aleon Pharma International, Inc. | 2 | $89,400 |
| MSR Technology Group LLC | 2 | $102,500 |
| Spark Life Solutions Inc. | 2 | $82,440 |
| Enso Law LLP | 2 | $73,834 |
| Summus Medical Laser, LLC | 2 | $50,170 |
| SG Healthcare and Pharma Tech, Inc. | 2 | $60,274 |
| Eli Lilly and Company | 2 | $79,310 |
| Axonics, Inc. | 2 | $101,000 |
| Arteriocyte Medical Systems, Inc. | 2 | $92,250 |
| Eurofins Lancaster Laboratories Professional Scientific Services, LLC | 2 | $52,000 |
| COSMAX USA Corporation | 2 | $78,374 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $65,000 |
| Nivo II (kalifye) | $77,313 |
| Nivo III (eksperyans) | $92,882 |
| Nivo IV (plen kompetans) | $106,490 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 107 | $79,082 |
| FY2024 | 97 | $75,982 |
| FY2025 | 102 | $75,991 |
| FY2026 | 99 | $85,904 |
Vil yo
- Sunnyvale, CA13
- New York, NY11
- Irvine, CA9
- Delran, NJ8
- Alameda, CA7
- East Brunswick, NJ7
- Santa Rosa, CA6
- Princeton, NJ6
- Los Angeles, CA6
- Bothell, WA6
- Austin, TX6
- Somerset, NJ5
- Fremont, CA5
- Plano, TX5
- Mounds View, MN5
- Indianapolis, IN5
- Whippany, NJ5
- Gaithersburg, MD5
- Raynham, MA5
- Saint Paul, MN4
- Raritan, NJ4
- Hauppauge, NY4
- San Jose, CA4
- Salt Lake City, UT4
- Provo, UT4
- Fridley, MN4
- Redondo Beach, CA4
- Lynnwood, WA4
- Santa Clara, CA4
- Union City, CA3
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).